Search

Anna Kathy Aman

Examiner (ID: 18092, Phone: (571)272-4515 , Office: P/2914 )

Most Active Art Unit
2914
Art Unit(s)
2914, 2973
Total Applications
3318
Issued Applications
3249
Pending Applications
17
Abandoned Applications
54

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 5784166 [patent_doc_number] => 20060204441 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-14 [patent_title] => 'Cell scaffold matrices with incorporated therapeutic agents' [patent_app_type] => utility [patent_app_number] => 11/084350 [patent_app_country] => US [patent_app_date] => 2005-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 23706 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0204/20060204441.pdf [firstpage_image] =>[orig_patent_app_number] => 11084350 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/084350
Cell scaffold matrices with incorporated therapeutic agents Mar 17, 2005 Issued
Array ( [id] => 478834 [patent_doc_number] => 07223748 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-05-29 [patent_title] => 'Pharmaceutical formulations for dry powder inhalers in the form of hard-pellets' [patent_app_type] => utility [patent_app_number] => 11/073625 [patent_app_country] => US [patent_app_date] => 2005-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9159 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 149 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/223/07223748.pdf [firstpage_image] =>[orig_patent_app_number] => 11073625 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/073625
Pharmaceutical formulations for dry powder inhalers in the form of hard-pellets Mar 7, 2005 Issued
Array ( [id] => 326301 [patent_doc_number] => 07514071 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-04-07 [patent_title] => 'Single-use cosmetic article' [patent_app_type] => utility [patent_app_number] => 11/074056 [patent_app_country] => US [patent_app_date] => 2005-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6967 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 143 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/514/07514071.pdf [firstpage_image] =>[orig_patent_app_number] => 11074056 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/074056
Single-use cosmetic article Mar 7, 2005 Issued
Array ( [id] => 7046225 [patent_doc_number] => 20050250820 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-10 [patent_title] => 'Therapeutic modulation of PPARgamma activity' [patent_app_type] => utility [patent_app_number] => 11/075090 [patent_app_country] => US [patent_app_date] => 2005-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 72353 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0250/20050250820.pdf [firstpage_image] =>[orig_patent_app_number] => 11075090 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/075090
Therapeutic modulation of PPARgamma activity Mar 6, 2005 Abandoned
Array ( [id] => 252699 [patent_doc_number] => 07579333 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-08-25 [patent_title] => 'Therapy using a combination of raloxifene and alendronate' [patent_app_type] => utility [patent_app_number] => 11/062272 [patent_app_country] => US [patent_app_date] => 2005-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9771 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 90 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/579/07579333.pdf [firstpage_image] =>[orig_patent_app_number] => 11062272 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/062272
Therapy using a combination of raloxifene and alendronate Feb 17, 2005 Issued
Array ( [id] => 7250526 [patent_doc_number] => 20050142196 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-30 [patent_title] => 'Stable pharmaceutical compositions containing an ACE inhibitor' [patent_app_type] => utility [patent_app_number] => 11/061816 [patent_app_country] => US [patent_app_date] => 2005-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2774 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20050142196.pdf [firstpage_image] =>[orig_patent_app_number] => 11061816 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/061816
Stable pharmaceutical compositions containing an ACE inhibitor Feb 17, 2005 Abandoned
Array ( [id] => 7233997 [patent_doc_number] => 20050256149 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-17 [patent_title] => 'Pharmaceutical compositions containing tiotropium salts and low-solubility salmeterol salts' [patent_app_type] => utility [patent_app_number] => 11/056968 [patent_app_country] => US [patent_app_date] => 2005-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5197 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0256/20050256149.pdf [firstpage_image] =>[orig_patent_app_number] => 11056968 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/056968
Pharmaceutical compositions containing tiotropium salts and low-solubility salmeterol salts Feb 10, 2005 Abandoned
Array ( [id] => 7110534 [patent_doc_number] => 20050207989 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-22 [patent_title] => 'High storage stability inhalable compositions' [patent_app_type] => utility [patent_app_number] => 11/054707 [patent_app_country] => US [patent_app_date] => 2005-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 2186 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0207/20050207989.pdf [firstpage_image] =>[orig_patent_app_number] => 11054707 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/054707
High storage stability inhalable compositions Feb 7, 2005 Issued
Array ( [id] => 5672084 [patent_doc_number] => 20060177438 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-10 [patent_title] => 'Methods of altering absorption of hydrophobic compounds' [patent_app_type] => utility [patent_app_number] => 11/053553 [patent_app_country] => US [patent_app_date] => 2005-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 11699 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0177/20060177438.pdf [firstpage_image] =>[orig_patent_app_number] => 11053553 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/053553
Methods of altering absorption of hydrophobic compounds Feb 7, 2005 Abandoned
Array ( [id] => 4548182 [patent_doc_number] => 07960370 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-06-14 [patent_title] => 'Type A gelatin capsule containing PUFA in free acid form' [patent_app_type] => utility [patent_app_number] => 10/587201 [patent_app_country] => US [patent_app_date] => 2005-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3864 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 167 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/960/07960370.pdf [firstpage_image] =>[orig_patent_app_number] => 10587201 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/587201
Type A gelatin capsule containing PUFA in free acid form Feb 6, 2005 Issued
Array ( [id] => 7098493 [patent_doc_number] => 20050130952 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-16 [patent_title] => 'Photodynamic therapy in selective cell inactivation in blood and treating immune dysfunction diseases' [patent_app_type] => utility [patent_app_number] => 11/048452 [patent_app_country] => US [patent_app_date] => 2005-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 8723 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20050130952.pdf [firstpage_image] =>[orig_patent_app_number] => 11048452 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/048452
Photodynamic therapy in selective cell inactivation in blood and treating immune dysfunction diseases Jan 30, 2005 Issued
Array ( [id] => 5220294 [patent_doc_number] => 20070161605 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-07-12 [patent_title] => 'Compounds and methods to increase anti-p-glycoprotein activity of baicalein by alkylation on the a ring' [patent_app_type] => utility [patent_app_number] => 10/586822 [patent_app_country] => US [patent_app_date] => 2005-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 17475 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0161/20070161605.pdf [firstpage_image] =>[orig_patent_app_number] => 10586822 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/586822
Compounds and methods to increase anti-P-glycoprotein activity of baicalein by alkylation on the A ring Jan 30, 2005 Issued
Array ( [id] => 6223411 [patent_doc_number] => 20100056623 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-04 [patent_title] => 'FUMAGILLOL DERIVATIVES OR METHOD FOR PREPARATION OF FUMAGILLOL DERIVATIVES, AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME' [patent_app_type] => utility [patent_app_number] => 11/814809 [patent_app_country] => US [patent_app_date] => 2005-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13372 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0056/20100056623.pdf [firstpage_image] =>[orig_patent_app_number] => 11814809 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/814809
FUMAGILLOL DERIVATIVES OR METHOD FOR PREPARATION OF FUMAGILLOL DERIVATIVES, AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME Jan 25, 2005 Abandoned
Array ( [id] => 418820 [patent_doc_number] => 07276492 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-10-02 [patent_title] => 'Use of ACE inhibitors for treatment of patients suffering from behavioral disorders' [patent_app_type] => utility [patent_app_number] => 11/037564 [patent_app_country] => US [patent_app_date] => 2005-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1814 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/276/07276492.pdf [firstpage_image] =>[orig_patent_app_number] => 11037564 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/037564
Use of ACE inhibitors for treatment of patients suffering from behavioral disorders Jan 17, 2005 Issued
Array ( [id] => 448919 [patent_doc_number] => 07250445 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2007-07-31 [patent_title] => 'Anti-oxidant suppository for treating radiation proctopathy and other anorectal disorders' [patent_app_type] => utility [patent_app_number] => 11/035513 [patent_app_country] => US [patent_app_date] => 2005-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2803 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 102 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/250/07250445.pdf [firstpage_image] =>[orig_patent_app_number] => 11035513 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/035513
Anti-oxidant suppository for treating radiation proctopathy and other anorectal disorders Jan 13, 2005 Issued
Array ( [id] => 5693763 [patent_doc_number] => 20060153910 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-13 [patent_title] => 'Lowering blood glucose, urea, cholesterol, triglycerides and normalizing homocysteine levels by dietary addition of selected essential amino acids and three vitamins' [patent_app_type] => utility [patent_app_number] => 11/041180 [patent_app_country] => US [patent_app_date] => 2005-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1057 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0153/20060153910.pdf [firstpage_image] =>[orig_patent_app_number] => 11041180 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/041180
Lowering blood glucose, urea, cholesterol, triglycerides and normalizing homocysteine levels by dietary addition of selected essential amino acids and three vitamins Jan 10, 2005 Issued
Array ( [id] => 6983984 [patent_doc_number] => 20050154054 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-14 [patent_title] => 'Stabilized ascorbic acid compositions and methods therefor' [patent_app_type] => utility [patent_app_number] => 11/032931 [patent_app_country] => US [patent_app_date] => 2005-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 7258 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0154/20050154054.pdf [firstpage_image] =>[orig_patent_app_number] => 11032931 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/032931
Stabilized ascorbic acid compositions and methods therefor Jan 10, 2005 Issued
Array ( [id] => 587117 [patent_doc_number] => 07435429 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-10-14 [patent_title] => 'Zinc salt compositions for the prevention of dermal and mucosal irritation' [patent_app_type] => utility [patent_app_number] => 11/031258 [patent_app_country] => US [patent_app_date] => 2005-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22769 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 117 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/435/07435429.pdf [firstpage_image] =>[orig_patent_app_number] => 11031258 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/031258
Zinc salt compositions for the prevention of dermal and mucosal irritation Jan 6, 2005 Issued
Array ( [id] => 6926552 [patent_doc_number] => 20050239809 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-27 [patent_title] => 'Methods for treating and preventing hypertension and hypertension-related disorders' [patent_app_type] => utility [patent_app_number] => 11/031477 [patent_app_country] => US [patent_app_date] => 2005-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 23427 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0239/20050239809.pdf [firstpage_image] =>[orig_patent_app_number] => 11031477 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/031477
Methods for treating and preventing hypertension and hypertension-related disorders Jan 6, 2005 Abandoned
Array ( [id] => 5380391 [patent_doc_number] => 20090192230 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-30 [patent_title] => 'Propofol-containing fat emulsion preparation' [patent_app_type] => utility [patent_app_number] => 10/585311 [patent_app_country] => US [patent_app_date] => 2005-01-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5247 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0192/20090192230.pdf [firstpage_image] =>[orig_patent_app_number] => 10585311 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/585311
Propofol-containing fat emulsion preparation Jan 5, 2005 Abandoned
Menu